Sonnet BioTherapeutics HoldingsSONN 
$1.001.01%24h
1.01%24h
Global rank35411
Market cap$1.04M
Change 7d19.05%
YTD Performance-42.53%
SP500 benchmarkUnderperform
P/E-0.06
P/S7.02
Revenue$147.81K
Earnings-$18.83M
Dividend yield-
Main Sector
Healthcare
Sonnet BioTherapeutics Holdings SONN Operating Margins
Operating Margin in 2022: -127.14%
According to Sonnet BioTherapeutics Holdings latest financial reports the company has an operating margin of -127.14%, an increase of 49.96% to 2022. At the end of 2022 company had an operating margin of -84.78%.
Sonnet BioTherapeutics Holdings Operating Margin from 2021 to 2024
-
Value:-
SONN Operating Margin History by year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | -127.14% | 49.96% |
| 2022 | -84.78% | 63.44% |
| 2021 | -51.87% | - |
View the highest operating margin companies 
